Skip to main content
. 2020 Jun 8;8(6):154. doi: 10.3390/biomedicines8060154

Figure 4.

Figure 4

Structural analyses of FFAR2 protein-ligand bindings with agonists–acetate (AD) and butyrate (EH) and an FFAR2 antagonist-CATPB ((S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)phenyl)butanoic acid) (IL) in the ribbon models (A,C,E,G,I,K) and two dimensional Ligplot images (B,D,F,H,J,K)) and of mice (A,B,E,F,I,J) and human (C,D,G,H,K,L).